AbbVie (NYSE: ABBV) director gains 1,118-share equity award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
FREYMAN THOMAS C reported acquisition or exercise transactions in this Form 4 filing.
AbbVie Inc. director Thomas C. Freyman received a grant of 1,118 restricted stock units of AbbVie common stock at a stated price of $0.00 per share. After this award, he directly holds 127,869 shares of AbbVie common stock.
The restricted stock units were granted under the AbbVie Amended and Restated 2013 Incentive Stock Program and will be paid one-for-one in AbbVie shares upon the earlier of his separation from service, death, or a defined change in control. Additional AbbVie shares are held in trusts for his spouse and son, totaling 1,941 shares and 4,000 shares respectively, for which he disclaims beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
FREYMAN THOMAS C
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.01 par value | 1,118 | $0.00 | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.01 par value — 127,869 shares (Direct, null);
Common Stock, $0.01 par value — 4,000 shares (Indirect, By spouse in trust)
Footnotes (1)
- These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities. Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.
Key Figures
RSU grant size: 1,118 units
Grant price per share: $0.00 per share
Direct holdings after grant: 127,869 shares
+2 more
5 metrics
RSU grant size
1,118 units
Restricted stock units awarded to director
Grant price per share
$0.00 per share
Stated price for RSU-related common stock
Direct holdings after grant
127,869 shares
AbbVie common stock held directly post-transaction
Spouse trust holdings
1,941 shares
Shares held by spouse in trust for son; beneficial ownership disclaimed
Irrevocable trust holdings
4,000 shares
Shares held in irrevocable trust for son; beneficial ownership disclaimed
Key Terms
restricted stock units, AbbVie Amended and Restated 2013 Incentive Stock Program, change in control, beneficial ownership
4 terms
restricted stock units financial
"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
AbbVie Amended and Restated 2013 Incentive Stock Program financial
"awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program")"
change in control financial
"on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
beneficial ownership financial
"The reporting person disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider transaction did AbbVie (ABBV) director Thomas C. Freyman report?
Thomas C. Freyman reported receiving 1,118 restricted stock units of AbbVie common stock as a grant. The units were awarded at a stated price of $0.00 per share under AbbVie’s 2013 Incentive Stock Program, reflecting routine director equity compensation.
When will Thomas C. Freyman’s AbbVie restricted stock units be paid out?
The 1,118 restricted stock units will be paid one-for-one in AbbVie common shares on the earlier of his separation from service, death, or a defined change in control. These payout conditions are set by AbbVie’s Amended and Restated 2013 Incentive Stock Program.
What is the role of trusts in Thomas C. Freyman’s AbbVie (ABBV) holdings?
AbbVie shares are also held in trusts benefiting his spouse and son, with 1,941 shares and 4,000 shares reported. His spouse serves as trustee, and the filing states that Freyman disclaims beneficial ownership of these trust-held securities.
Is the AbbVie (ABBV) Form 4 transaction a market purchase or sale?
No market purchase or sale is reported. The Form 4 shows a grant of 1,118 restricted stock units at a stated price of $0.00 per share, categorized as a grant or award acquisition rather than an open-market buy or sell transaction.